Authors
Celestino Neves, João Sérgio Neves, Oksana Sokhatska, Luís Delgado
Published in
Frontiers in endocrinology. Volume 17. Pages 1865915. Epub Oct 05, 2026.
Abstract
Autoimmune thyroiditis (AIT) has been associated with an increased cardiovascular risk. Whether adipokines, inflammation and auto-immunity contribute to this increased risk is uncertain. Our aim was to evaluate the interrelationships of adipokines, inflammation, auto-immunity, and thyroid function with cardiovascular risk in autoimmune thyroiditis.
Sixty-two patients with AIT, with normal free T4 (FT4) and free T3 (FT3), without other comorbidities were studied. Patients were divided into two groups: AIT with thyroid-stimulating hormone (TSH) ≤2.5 mU/L and AIT with TSH >2.5 mU/L. Parameters of thyroid function tests, serum lipid, high sensitivity C-reactive protein (hs-CRP) and homocysteine levels, anti-thyroglobulin antibodies, anti-thyroid peroxidase (TPO) antibodies, adiponectin and resistin were measured.
Patients with TSH >2.5 mU/L had significantly higher body mass index, higher low density lipoprotein (LDL)-cholesterol levels, and lower lipoprotein(a) levels. No differences in triglycerides, apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), adiponectin, or resistin levels were observed between groups. In the overall cohort, adiponectin levels were positively correlated with high density lipoprotein (HDL)-cholesterol and lipoprotein(a), whereas resistin was positively correlated with hs-CRP and triglyceride levels. Hs-CRP levels were positively correlated with anti-thyroglobulin antibody titers, and homocysteine levels were negatively correlated with FT3. In the subgroup with TSH >2.5 mU/L, FT4 was positively correlated with ApoA1 and HDL-cholesterol and negatively correlated with lipoprotein(a), while resistin was positively correlated with TSH. In patients with TSH ≤2.5 mU/L, adiponectin levels were negatively correlated with TSH.
Our study highlights a complex interrelationship between cardiovascular risk factors in patients with AIT. Patients with AIT and TSH >2.5 mU/L may have a more atherogenic lipid profile.
PMID:
42898201
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 21
- Comments 0